Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,305
Closed -$1.35M 240
2024
Q1
$1.35M Sell
17,305
-62,100
-78% -$4.62M 0.13% 258
2023
Q4
$5.67M Buy
79,405
+54,744
+222% +$3.81M 0.6% 18
2023
Q3
$1.71M Sell
24,661
-392
-2% -$29.6K 0.21% 179
2023
Q2
$2.03M Buy
+25,053
New +$2.05M 0.26% 151
2022
Q1
Sell
-45,905
Closed -$3.51M 713
2021
Q4
$3.51M Buy
+45,905
New +$3.37M 0.38% 77
2021
Q1
Sell
-4,893
Closed -$356K 606
2020
Q4
$356K Buy
+4,893
New +$345K 0.03% 484
2020
Q3
Sell
-5,807
Closed -$331K 611
2020
Q2
$331K Buy
+5,807
New +$285K 0.03% 337
2020
Q1
Sell
-27,745
Closed -$1.45M 149
2019
Q4
$1.45M Sell
27,745
-18,625
-40% -$927K 0.09% 232
2019
Q3
$2.34M Buy
46,370
+22,430
+94% +$1.1M 0.13% 192
2019
Q2
$1.15M Sell
23,940
-101,590
-81% -$4.7M 0.1% 178
2019
Q1
$6.08M Buy
+125,530
New +$5.66M 0.36% 77

Other funds holding HOLX

Duality Advisers's HOLX Position: Q2 2024 in Review

Duality Advisers sold out of Hologic (HOLX) in Q2 2024, closing a stake of 17,305 shares — an estimated $1.35M sold.

Duality Advisers first reported a position in HOLX in Q1 2019 and held it in 11 quarters. The position peaked at $6.08M in Q1 2019. 702 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

  • Duality Advisers reported no remaining Hologic position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 17,305 Hologic shares in Q2 2024, an estimated $1.35M.
  • Duality Advisers first reported a position in Hologic in Q1 2019 and held it in 11 quarters.
  • Duality Advisers's Hologic position peaked at $6.08M in Q1 2019.
  • 702 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.